Lexpos News

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Cefalexin 125mg/5ml and 250mg/5ml oral suspensions, sugar free MSN/2024/113 Tier 2 – medium impact Date of issue: 13th December 2024 Cefalexin 125mg/5ml and 250mg/5ml oral suspension (sugar free) are out of stock until mid-2025 Cefalexin 125mg/5ml and 250mg/5ml oral suspension (non [...]

The post Medicine Supply Notification: Cefalexin 125mg/5ml and 250mg/5ml oral suspensions, sugar free appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Insulatard® (isophane insulin, human) Penfill® 100units/ml suspension for injection 3ml cartridges TO NOTE: This is the second of three MSNs covering discontinuations of Novo Nordisk insulin products (NovoRapid® FlexTouch®, Insulatard® Penfill® and all Levemir® presentations). A third MSN will provide clinical [...]

The post Medicine Supply Notification: Insulatard® (isophane insulin, human) Penfill® 100units/ml suspension for injection 3ml cartridges appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 5 December 2024) has been published and includes articles on: Letters and medicine recalls sent to healthcare professionals in November 2024 To see th...

Today the Government announced that regulations restricting the prescribing and supply of puberty-suppressing hormones – which were due to expire at the end of December –will be made indefinite. The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024 will come into force on 1 January 2025 as the current emergency order expires and [...]

The post Legislation restricting the sale and supply of gonadotrophin-releasing hormone analogues will be made indefinite appeared first on Community Pharmacy England.

The Managing Director of Jardines (UK) Ltd and Superintendent Pharmacist of Pearl Chemist Group have been selected as non-CCA multiple observers to the Community Pharmacy England Committee. The establishment of two contributing observer places is an interim measure to ensure pharmacy owners with 10 or more pharmacies are well represented, while the Committee considers more [...]

The post Additional non-CCA multiples appointed to Community Pharmacy England Committee appeared first on Community Pharmacy England.